Description
A hypoxia-activated anticancer agent; is converted to an oxidizing radical under hypoxic conditions; can induce single- and double-strand breaks in DNA, formation of trapped topoisomerase I- and II-DNA complexes, and other chromosomal aberrations, leading to cytotoxicity; induces hypoxia-enhanced cytotoxicity in DT40 cells (IC50s = 1.02 and 4.34 μM in hypoxic and normoxic conditions, respectively); induces cytotoxicity in HT-1080 and A549 cells in a concentration-dependent manner under hypoxic conditions; sensitizes tumors to cisplatin in a mouse RIF-1 fibrosarcoma tumor model; sensitizes tumors to fractionated irradiation in a FaDu hypopharyngeal squamous cell carcinoma mouse xenograft model at (0.08 mmol/kg)
Formal name: 1,2,4-benzotriazin-3-amine 1,4-dioxide
Synonyms: 3-Amino-1,2,4-benzotriazine 1,4-Dioxide|SR 259075|SR 4233|WIN 59075
Molecular weight: 178.2
CAS: 27314-97-2
Purity: ≥98%
Formulation: A solid
Product Type|Biochemicals||Research Area|Cancer|Cell Death||Research Area|Cancer|DNA Damage and Repair||Research Area|Oxidative Stress & Reactive Species|DNA/RNA Oxidative Damage